Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2014-12-19 Regulatory Filings
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Progress on EU zone approval
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and the date, which are hallmarks of regulatory news service announcements, typically used by UK-listed companies. The content discusses an update on the regulatory approval process for a product (3AEY) in the Southern EU zone, quoting the CEO and providing contact details for advisors. This is a specific operational update concerning regulatory progress, not a full financial report (like 10-K or IR) or a general announcement of a report's publication (RPA). Since it is a specific, non-financial regulatory update that doesn't fit the other specific categories (like DIRS, DIV, MANG), the most appropriate classification is the general regulatory announcement category, RNS.
2014-12-19 English
Licence Agreement with SUMIAGRO
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and the date '01 December 2014', indicating it is a regulatory announcement disseminated via the Regulatory News Service (RNS). The content details a significant business event: the signing of an exclusive Licence Agreement for a plant protection product. This type of announcement—a material business development or contract signing released to the market via an official channel—is typically classified as a general regulatory filing or announcement, especially when it doesn't fit neatly into specific financial reporting categories (like 10-K, ER, or DIV). Since it is a formal, non-financial-statement regulatory update, the most appropriate general category is Regulatory Filings (RNS). It is not a full report (like 10-K or IR), nor is it a management change (MANG) or a dividend notice (DIV).
2014-12-01 English
Conversion of all outstanding debt
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a significant corporate action: the conversion of all outstanding debt (£2,295,192) into new ordinary shares (20,865,382) and the subsequent change in the total number of shares in issue. This action directly relates to the company's capital structure and financing. While it involves shares, it is a specific announcement about debt settlement rather than a general share issue (SHA) or a buyback (POS). Since it is a formal regulatory announcement disseminated via the RNS system that doesn't fit perfectly into the other specific financial event categories (like ER, IR, DIV), the most appropriate classification is the general regulatory announcement category, RNS, as per the provided definitions and the document's source.
2014-11-28 English
Placing to raise £750,000
Share Issue/Capital Change Classification · 99% confidence The document begins with an 'RNS Number' and is dated 21 November 2014. The content announces a 'Placing to raise £750,000' through the issuance of new ordinary shares. This action directly relates to fundraising, financing activities, and changes in the capital structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it is distributed via RNS, the core subject matter is financing, making CAP the most specific and accurate classification over the general RNS fallback.
2014-11-21 English
Licence Agreement with SIPCAM
M&A Activity Classification · 99% confidence The document begins with an 'RNS Number' and is dated 21 November 2014. The content announces a specific corporate event: 'Eden Research plc announces that it has signed an exclusive Licence Agreement with Sipcam Italia Spa and Sipcam Iberia'. This is a material announcement regarding a business development (licensing deal) that is being disseminated via the Regulatory News Service (RNS) system of the London Stock Exchange. Since it is a specific, material corporate announcement that doesn't fit into the defined categories like M&A (TAR), Capital Change (CAP), or Director's Dealing (DIRS), and it is clearly an official regulatory dissemination, the most appropriate classification is the general regulatory announcement category, RNS. It is not a full report (10-K, IR), a transcript (CT), or a presentation (IP).
2014-11-21 English
Successful trials in Greece to combat Botrytis
Regulatory Filings Classification · 98% confidence The document is a press release issued via the London Stock Exchange's Regulatory News Service (RNS). It details operational updates regarding successful product trials in Greece for Eden Research plc. Since it is a general corporate announcement regarding business operations and product development that does not fit into specific categories like financial reports, dividends, or M&A, it is classified as a Regulatory Filing (RNS).
2014-09-29 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.